260 likes | 435 Views
Towards the development of an amperometric immunosensor for the determination of Ochratoxin A. Introduction. World Health Organization. Mycotoxins (from fungi) Phycotoxins (from algae) Toxins from edible plants
E N D
Towards the development of an amperometric immunosensor for the determination of Ochratoxin A
Introduction World Health Organization • Mycotoxins (from fungi) • Phycotoxins (from algae) • Toxins from edible plants Regulations to protect public health and economical interests of producers and traders
O C O O H O O H N O H C H 3 Cl Introduction Ochratoxin A (OTA): 7-(L-b-phenylalanyl-carbonyl)-carboxyl-5-chloro-8-hydroxy-3,4-dihydro-3R-methylisocoumarin • OTA occurs when food with a high water content is not properly dried • Effects on animals: nephrotoxic, hepatotoxic, neurotoxic, immunotoxic, genotoxic, teratogenic, myelotoxic and carcinogenic (in mice and rats) properties • Effects on humans: - Group 2B (possible human carcinogen) - Main target organ: kidneys. Nephropaties
Introduction OTA in foodstuffs: • Cereals (corn, barley, rice,…) and cereal products • Cocoa and cocoa products • Coffee (roasted or soluble) • Species • Dried vine fruits (currants, raisins and sultanas) • Meat and meat products • Beer • Grape juice and must • Wine 5 ppb 5-10 ppb 10 ppb 2 ppb 2 ppb
Introduction Analytical methods used for OTA determination • Extraction using organic solvents • Purification through chromatographic columns • Detection HPLC with fluorescence detection GC/MS Capillary electrophoresis with fluorescence detection (induced by laser)
Introduction Commercial kits for OTA based on Enzyme-Linked Immunosorbent Assays (ELISA) • Direct competitive assays R-Biopharm (LOD:5 ppb) Romer Labs (2-40 ppb LOD:2 ppb) Neogen (2-25 ppb LOD:1 ppb) • Indirect competitive assays Biosystems (1-50 ppb LOD:1 ppb)
Electrochemical immunosensors more sensitive cost-effective instrumentation possible miniaturization portable device possibility of a high throughput sample SPEs Introduction Our purpose… • Immunoassays good selectivity good sensitivity wide variety of applications Wells
Enzyme substrate Enzyme product IgG-enzyme conjugate anti-OTA PAb OTA anti-OTA PAb OTA-BSA Screen-printed electrode Introduction Our purpose… • Development of an immunosensor for OTA determination based on an electrochemical detection
N N + O C O O H O O H N N N O O O H R1 C 10 min at room T protected from light constant stirring O H C H 3 Cl O + + CO2 N N N N H H R1 N N + O added dropwise + R2 R2 N H 2 h constant stirring R1 N 2 H OTA-BSA BSA OTA-BSA conjugate Synthesis of OTA-BSA
anti-OTA PAb Enzyme substrate Enzyme product IgG-enzyme conjugate anti-OTA PAb OTA OTA-BSA Screen-printed electrode Immunosensor Immunosensor Strategy 1
Immunosensor Immunosensor Checkerboard on wells • [OTA-BSA] = 0.2 µg/mL • [anti-OTA] = 1:100 • [IgG-HRP] = 1:6000 • 1 h competition (10 µL anti-OTA + 90 µL OTA) • 1 h incubation (IgG-enzyme conjugate)
1.2 1.0 0.8 IgG-HRP 0.6 IgG-AP 0.4 0.2 Abs(relative) (620 or 405 nm) 0.0 -5 -4 -3 -2 -1 0 [anti-OTA]= 2mg/ml log(dilution of IgG-enzyme conjugate) Immunosensor IgG-enzyme conjugate Saturation dilutions: - 1:1500 IgG-HRP - 1:250 IgG-AP Approx. 80%: -1:6000 dilution of IgG-HRP -1:1000 dilution of IgG-AP 0.5, 1, 4, 8, 12 and 16 mg/mL p-NPP in 10% DEA buffer, pH 9.8
100 80 IgG-AP 60 % of absorbance IgG-HRP 40 20 0 -3 -2 -1 0 1 2 log([OTA] (mg/ml)) Immunosensor Colourimetric OTA detection (ELISA wells) • IC50 (IgG/HRP) = 341 µg/L • IC30 (IgG/HRP) = 58 µg/L • IC10 (IgG/HRP) = 10 µg/L • IC50 (IgG/AP) = 1366 µg/L • IC30 (IgG/AP) = 390 µg/L • IC10 (IgG/AP) = 111 µg/L n = 4
Immunosensor Immunosensor Checkerboard on SPEs • [OTA-BSA] = 0.2 µg/mL • [anti-OTA] = 1:100 • [IgG-HRP] = 1:500 • [IgG-AP] = 1:750 • 1 h competition (10 µL anti-OTA + 90 µL OTA) • IgG-enzyme conjugate incubation: 1 h in milk
120 100 80 60 % of absorbance 40 20 0 -3 -2 -1 0 1 2 log([OTA] (mg/ml)) Immunosensor Colourimetric OTA detection (SPE) IgG-HRP • IC50 (IgG/HRP) = 7841 µg/L • IC30 (IgG/HRP) = 311 µg/L • IC10 (IgG/HRP) = 12 µg/L • IC50 (IgG/AP) = 2363 µg/L • IC30 (IgG/AP) = 332 µg/L • IC10 (IgG/AP) = 47 µg/L IgG-AP n = 4
0.05 0 -0.05 -0.10 i (mA) -0.15 -0.20 -0.25 -0.30 -0.35 -0.3 -0.2 -0.1 0 0.1 E (V vs. Ag/AgCl) Immunosensor Electrochemical detection • MPMS(N-methylphenazonium methyl sulfate) Chronoamperometry (single-drop analysis) 2 min substrate incubation Ereading = - 0.2 V for 20 sec MPMS MPMS + HRP + H2O2 0.2 mM MPMS + 20 mM H2O2 in 100 mM acetate buffer with NaCl
100 80 60 % of absorbance 40 20 0 -3 -2 -1 0 1 2 log([OTA] (mg/ml)) Immunosensor Electrochemical detection MPMS in solution IgG-HRP • IC50 = 1089 µg/L • IC30 = 234 µg/L • IC10 = 51 µg/L n = 3 Total system: 5523 nA (12.6 %) No IgG-HRP: 3509 nA (4.8 %) No anti-OTA: 3500 nA (5.0 %) No H2O2: 3333 nA (7.6 %) No MPMS: 1040 nA (7.1 %)
Conclusions Conclusions • Strategy 1 allows the colourimetric detection of OTA, using wells and SPEs, and the development of an electrochemical immunosensor for the determination of this mycotoxin. • Both IgG-enzyme conjugates, with HRP or AP, can be used. Up to now, good results are observed when working with an electrochemical mediator (MPMS) in solution for the determination of HRP. • However, work is in progress since our aim is to achieve lower limits of detection (0.05-0.1 µg/L).
anti-OTA PAb Enzyme substrate Enzyme product IgG-enzyme conjugate anti-OTA PAb OTA biotin-OTA SAv Screen-printed electrode Future work Strategy 2
Enzyme substrate Enzyme product SAv-enzyme conjugate biotin-OTA OTA anti-OTA PAb Screen-printed electrode Future work Strategy 3
Enzyme substrate Enzyme product OTA-enzyme conjugate OTA anti-OTA PAb Screen-printed electrode Future work Strategy 4
anti-OTA PAb anti-OTA PAb OTA biotin-OTA Av Quartz • Development of an immunosensor for OTA determination based onQCM detection
Development of an immunosensor for OTA determination based on QCM detection Quartz of oscillation frequence of 27 MHz
Streptavidin-Au OTA Av biotin-OTA anti-OTA PAb Gold electrode • Development of an immunosensor for OTA determination based on impedimetric detection